Professionals 224 Users Online

Membrane Oxygenators Market

Surge in cardiopulmonary disorders to upscale the demand for membrane oxygenators: Opportunities ahead

Global Membrane Oxygenators Market by Product Type (Hollow Fiber Membrane Oxygenators and Flat Sheet Membrane Oxygenators)

Market Snapshot

Newly-released Membrane Oxygenators Market analysis report by Persistence Market Research shows that global sales of Membrane Oxygenators Market in 2021 were held at US$ 134 Mn. With a CAGR of 2% during 2022 - 2032, the market is projected to reach a valuation of US$ 166 Mn by 2032.

Hollow Fiber Membrane Oxygenators is expected to be the highest revenue-generating segment, projected to grow at a CAGR of over 1.9% during 2022 – 2032.

Attribute

Details

Global Membrane Oxygenators Market (2022)

US$ 136.5 Mn

Global Membrane Oxygenators Market (2032)

US$ 166.1 Mn

Global Membrane Oxygenators Market CAGR (2022 – 2032)

2%

U.S. Membrane Oxygenators Market CAGR (2022 – 2032)

2.1%

Key Companies Profiled

  • MicroPort Scientific Corporation
  • Nipro Medical Corporation
  • Medtronic
  • Fresenius SE & Co KGaA
  • Terumo Medical Corporation
  • Getinge AB
Sample Report

FREE Report Sample is Available

In-depth report coverage is now just a few seconds away

Download PDF Get FREE Report Sample

Revenue of Membrane Oxygenators Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Membrane Oxygenators Market research by Persistence Market Research - a market research and competitive intelligence provider, historically, from 2017 the to 2021, market value of the Membrane Oxygenators Market increased at around 1.7% CAGR.

The increased frequency of cardiopulmonary disorders is predicted to drive the growth of membrane oxygenators throughout the forecast period. Cardiopulmonary illnesses are primarily caused by a poor diet, lack of physical activity, cigarette use, and smoking. Membrane oxygenators are projected to become more popular in pediatric, adult, and elderly patients as the prevalence of cardiovascular disorders rises. The market is expected to register an absolute dollar growth value of US$ 29.5 Mn during the forecast period.

Custom Report Cover

Make This Report Your Own

Take Advantage of Intelligence Tailored to your Business Objective

> Get a Customized Version

Which Factors are Propelling Membrane Oxygenators Demand?

The rising prevalence of respiratory and cardiovascular disorders, as well as the expanding number of extracorporeal membrane oxygenator centers and the rising use of membrane oxygenators as a bridge to lung transplantation, are contributing to the market's expansion. Increased usage of oxygenators due to the availability of infant and adult-specific devices is likely to help the market expansion over the forecast period.

Membrane oxygenators are employed in the treatment of acute respiratory insufficiency for long-term maintenance. Because of improvements in mass transfer efficiency and membrane technology, membrane types are replacing bubble oxygenators for Cardiopulmonary Bypass (CPB), which is driving market expansion. The new technologies are broadening the range of potential uses for these devices in various ways, including the ability to make membrane oxygenators mobile for both inter and intra-hospital transfer.

Market Research Methodology

Market Research Methodology

-Perfect through Years of Diligence

Check Research Methodology

What are the restraints of the Membrane Oxygenators Market?

The implementation of minimally invasive procedures such as the risks associated with oxygenation systems, percutaneous coronary interventions, and the strict US FDA regulations for Class II category devices, which must meet performance standards, are acting as restraints to the market growth.

Sales Team

Sales Team
Client Partner

Let's Connect

Connect me to identify winning opportunities

Ask An Expert
I'm Available

Region-wise Insights

Which Region is projected to Offer the Largest Opportunity for Membrane Oxygenators?

North America dominated the market, which is expected to account for a market share of over 35% throughout the analysis period. The regional market growth is aided by the presence of well-developed primary, secondary, and tertiary care hospitals. The presence of a well-developed reimbursement network, attractive government funding, and growing awareness about membrane oxygenator machines are helping to increase their usage in hospitals. In addition, technological improvements in membrane oxygenators are boosting market expansion.

In Asia Pacific, the growing incidence of chronic conditions including heart disease as a result of poor eating habits and increased cigarette consumption, as well as increased awareness of membrane oxygenators, has led to greater adoption of it.

Several government initiatives, as well as the rate of success of ECMO devices throughout cardiothoracic operations, are expected to boost market growth. The large population in Asia Pacific with low per capita income has resulted in a higher requirement for cost-effective treatment options. Multinational firms are planning investments in emerging countries such as China. This is projected to boost the regional market in the future.

Country-wise Insights

U.S. Membrane Oxygenators Market Analysis

The market in the U.S. is projected to reach a valuation of US$ 58 Mn by 2032. Growing at a CAGR of 2.1% during 2022 – 2032, the market in the country is expected to gross an absolute dollar opportunity of US$ 11 Mn.

U.K. Membrane Oxygenators Market Analysis

The market in the country is expected to reach US$ 6.4 Mn by 2032. During the forecast period, the market in the country is expected to garner an absolute dollar opportunity of US$ 900 Mn during 2022 - 2032.

Japan Membrane Oxygenators Market Analysis

In Japan, the market is projected to reach US$ 6.2 Mn by 2032. The market in the country is expected to gross US$ 1.2 Mn in absolute dollar opportunity during 2022 - 2032.

Category-wise Insights

Which Product type of Membrane Oxygenator is expected to Score the Highest Growth in the Coming Years?

The hollow fiber membrane oxygenators segment dominated the market and is expected to account for a CAGR of 1.9% CAGR during the forecast period. Hollow-fiber membrane oxygenators have a large number of fibers with semi-porous walls and a central lumen with large holes for moving water. These fibers are tiny enough that proteins, primarily plasma proteins, can fill in the gaps, forming a semipermeable membrane or thin film that allows gas exchange.

The perforations in hollow-fiber membrane oxygenators allow gas to escape, quickly de-airing the fibers. As a result, these oxygenators have been included in a few ECLS circuits as a fast response system for support following cardiac shock or arrest, which is helping this segment to score the highest growth.

The flat sheet membrane oxygenators have no pores in the membrane and rely on the permeability of the plastic material to allow gas to pass through. To avoid air trapping in a part with blood, flat sheet membrane oxygenators require cleansing the air outside the membrane with a soluble gas, such as carbon dioxide. Flat sheet membrane oxygenators also offer a longer life cycle, with permission for use up to 14 days, compared to hollow-fiber oxygenators, which need to be replaced every 6 to 12 hours in most circumstances. Over the forecasted period, this will increase the adoption.

Which Age group of Membrane Oxygenators is expected to offer Significant Opportunity in the Forthcoming Years?

Patients with chronic respiratory and cardiovascular illnesses are treated with membrane oxygenators. The adult segment led the market, accounting for 1.6% CAGR from 2017 to 2021. Cardiogenic shock is the most common indication of the requirement for membrane oxygenation in adult heart failure. Membrane oxygenator technology has improved, allowing it to be used in the treatment of adults.

Advanced designs, pump-less veno-arterial extracorporeal gas support systems, double-lumen cannula, and respiratory dialysis are among the technological breakthroughs that are helping to increase sales. Before ECMO may be incorporated into an adult treatment plan, a number of parameters must be addressed, including the degree of organ failure, weight, concurrent diseases, and age which impact the patient's diagnosis.

Over the projection period, the neonate sector is expected to grow at a significant rate. A membrane oxygenator is widely utilized for infants suffering from respiratory and cardiac failure. ECMO patients account for 44.8% of newborns, as per the Extracorporeal Life Support Organization (ELSO) registry report, with roughly 40,000 newborns treated with ECMO globally.

The need for membrane oxygenators is projected to rise as the number of newborns grows. However, due to the recent emergence of minimally invasive means of therapy for newborn respiratory insufficiency, which restricts segment expansion, the overall number of neonates treated with membrane oxygenators is declining dramatically over time.

Which Application of Membrane Oxygenators is expected to Score Highest Growth in the Coming Years?

The membrane oxygenator market was driven by the respiratory sector in the application category. Patients with severe respiratory illnesses, such as respiratory failure, are frequently treated using membrane oxygenators. Hypertension, respiratory failure, meconium aspiration syndrome, respiratory distress, and severe pneumonia are among the conditions for which they are used.

Membrane oxygenators act as artificial lungs in the case of respiratory disorders, assisting in the maintenance of pulmonary function. Globally, respiratory disorders such as asthma are on the rise, fuelling the need for membrane oxygenators throughout the predicted period.

What is the impact of Covid-19 on the Membrane Oxygenators Market?

During the pandemic, these oxygenators were heavily used in acute Covid-19 conditions. The capabilities of these oxygenators are rapidly expanding. Companies are also boosting the manufacturing of oxygenators internationally to assist the adoption of ECMO methods for the treatment of COVID-19 patients in order to deal with the COVID-19 pandemic. The need for oxygenators in intensive care units has skyrocketed. Furthermore, these devices are crucial in critical care surgical procedures and the management of COVID-19 patients; as a result, market players are releasing solutions that include an oxygenator.

Competitive Analysis

There are several significant competitors in the oxygenators market, which is moderately competitive. A few major competitors are producing new products with advanced technologies to compete with existing items, while others are purchasing and teaming with other market-leading businesses. Some of the key players in the market include MicroPort Scientific Corporation, Nipro Medical Corporation, Medtronic, Fresenius SE & Co KGaA, Terumo Medical Corporation, and Getinge AB.

Some of the recent developments of Membrane Oxygenators market key providers are as follows:

  • In November 2021, the National Medical Products Administration (NMPA) of China granted the Vitasprings Spiral Diversion Integrated Membrane Oxygenator, formed by MicroPort Kewei, a subsidiary of MicroPort Scientific Corporation MicroPort, access to the 'Green Path' special approval procedure for innovative medical devices.
  • In February 2020, as per Fresenius Medical Care North America, the US Food and Drug Administration (FDA) approved Novalung, a lung, and heart support system, for the prevention of chronic respiratory or cardiopulmonary failure (FMCNA). Novalung is the first extracorporeal membrane oxygenation (ECMO) system to be approved for usage beyond six hours.

Market Segments Covered in Membrane Oxygenators Market Analysis

By Type

  • Hollow Fiber Membrane Oxygenators
  • Flat Sheet Membrane Oxygenators

By Age Group

  • Neonates
  • Pediatrics
  • Adults

By Application

  • Respiratory
    • Respiratory failure
    • Pulmonary embolism
    • Acute respiratory distress syndrome
    • Pneumonia
    • COVID-19
  • Cardiac
    • Acute myocardial infarction
    • Myocarditis
    • Post-transplant complications
    • Decompensated cardiomyopathy
    • Cardiogenic shock
  • ECPR

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa(MEA)

- Companies Covered in This Report -

  • MicroPort Scientific Corporation
  • Nipro Medical Corporation
  • Medtronic
  • Fresenius SE & Co KGaA
  • Terumo Medical Corporation
  • Getinge AB

- Frequently Asked Questions -

The market is worth more than US$ 134 Mn at present.

The market value is projected to increase at a CAGR of around 2% during 2022 – 2032.

The market value increased at a CAGR of around 1.7% during 2017 – 2021.

The rising prevalence of respiratory and cardiovascular disorders, the expanding number of extracorporeal membrane oxygenator centers, and the rising use of membrane oxygenators as a bridge to lung transplantation are contributing to the market's expansion.

The market for Membrane Oxygenators in China is projected to expand at a CAGR of around 2.5% during 2022 – 2032.

While the market in South Korea is expected to grow at nearly 1.7%, the market in Japan is projected to register a CAGR of nearly 2.2% during 2022 - 2032.

This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy
Google translate